Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Desitin Arzneimittel GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10930
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Desitin Arzneimittel GmbH (Desitin) formerly Desitin Compagnie mbH, is a specialty pharmaceutical company which develops and produces products for the treatment of central nervous system (CNS) related neurological and psychiatric diseases. Its product portfolio includes antiepileptic drugs and antiparkinson medication. It offers medicines for illnesses such as Parkinson’s disease, epilepsy, dystonia, actinic keratosis, and post-stroke spasticity. Desitin also provides active pharmaceutical ingredients (APIs), besides manufacturing, clinical development, regulatory support, market access and health care services. It markets and distributes its products through a network of partner companies across Europe. The company has operations with offices in Denmark, Sweden, Norway, Czech Republic, Slovakia, Romania, Switzerland and the UK. Desitin is headquartered in Hamburg, Germany.

Desitin Arzneimittel GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Desitin Arzneimittel Enters Into Co-Promotion Agreement With GlaxoSmithKline For Elontril 10
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 11
Licensing Agreements 12
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 13
Desitin Arzneimittel GmbH – Key Competitors 14
Desitin Arzneimittel GmbH – Key Employees 15
Desitin Arzneimittel GmbH – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Desitin Arzneimittel GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Desitin Arzneimittel Enters Into Co-Promotion Agreement With GlaxoSmithKline For Elontril 10
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 11
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 13
Desitin Arzneimittel GmbH, Key Competitors 14
Desitin Arzneimittel GmbH, Key Employees 15
Desitin Arzneimittel GmbH, Subsidiaries 16

List of Figures
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Slavneft-Yaroslavnefteorgsintez (JNOS):企業財務及び戦略的SWOT分析
    Summary Slavneft-Yaroslavnefteorgsintez (Slavneft-YANOS), a subsidiary of Slavneft is an oil and gas company that offers refined petroleum products. The company offers oil products such as bitumen, motor gasoline, and diesel fuel of euro 5 standard, jet fuel, motor oil, transmission oil, turbine oil …
  • Saft Groupe SA-エネルギー分野:企業M&A・提携分析
    Summary Saft Groupe SA (Saft), a subsidiary of Total SA, is a designer, developer, and manufacturer of batteries. The company provides non-rechargeable and rechargeable batteries thorough nickel, primary lithium, lithium-ion, and other technologies. It offers systems integration, and various turnkey …
  • ValiRx Plc (VAL):企業のM&A・提携動向(医療分野)
    Summary ValiRx Plc (ValiRx) is a biopharmaceutical company that develops technologies and therapeutic options for the treatment of cancer. The company’s products and technology include GeneICE-silencing rebellious genes, GeneICE – BCL-2, VAL201-prostate cancer, NAV3 cancer screening test and VAL401- …
  • Staffline Group PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Staffline Group PLC Mergers and …
  • MModal IP LLC.:企業のM&A・提携動向(医療機器分野)
    Summary MModal IP LLC. (MModal) is a provider of clinical transcription services and clinical documentation workflow solutions. The company's product portfolio comprises M*Modal Fluency Direct, M*Modal Fluency for Coding, M*Modal Fluency for Imaging, M*Modal Fluency for Practices, M*Modal Fluency fo …
  • CK Infrastructure Holdings Ltd (1038):企業の財務・戦略的SWOT分析
    CK Infrastructure Holdings Ltd (1038) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Brewers Fayre:企業の戦略・SWOT・財務分析
    SummaryBrewers Fayre - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Almac Discovery Ltd.(製薬・医療分野):企業M&A動向
    Summary Almac Discovery Ltd. (Almac) is a pharmaceutical company. The company discovers and develops drugs for the treatment of cancer. It develops drugs, small molecule and peptide therapeutics, biomarkers, and diagnostic tools. Almac offers products such as ALM101, a nasal formulation of the 5HT-3 …
  • Great Plains Energy Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Great Plains Energy Incorporate …
  • Pivotal Therapeutics Inc. (PVO)(製薬・医療分野):企業M&A動向
    Summary Pivotal Therapeutics Inc. (Pivotal Therapeutics) is a pharmaceutical company. The company produces and markets therapeutic products for cardiovascular disease and overall health. Its products include VASCAZEN and OMAZEN. Pivotal Therapeutics’s VASCAZEN is a medical food formulated for the di …
  • Sitestar Corporation (SYTE):企業の財務及び戦略的SWOT分析
    Summary Sitestar Corporation (Sitestar) is an internet solution provider that offers consumer and business-grade internet access, wholesale managed modem services for downstream ISPs and web hosting services. The company’s services include internet access services, web acceleration services, web hos …
  • Balmer Lawrie & Co. Ltd. (BALMLAWRIE):企業の財務及び戦略的SWOT分析
    Summary Balmer Lawrie & Co. Ltd. (Balmer Lawrie) a subsidiary of Balmer Lawrie Investments Ltd. is a general business company that offers petroleum products. The company provides greases and lubricants. Its products include provide include multipurpose greases, extreme pressure greases, molybdenum g …
  • Covance, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Covance, Inc. Mergers and Acqui …
  • Masisa S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Masisa S.A. Mergers and Acquisi …
  • LMG Chemicals Corporation (LMG):企業概要、財務及び戦略的SWOT分析
    Summary LMG Chemicals Corporation (LMG) is a chemical manufacturing company. The company manufactures semi processed products. Its products include sulfuric acid and sulfur flakes. LMG sulfuric acid and sulfur flakes are used in leaching copper oxide ore, pickling iron and steel, production of alum …
  • Ashot Ashkelon Industries Ltd.:企業の戦略・SWOT・財務分析
    SummaryAshot Ashkelon Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • MedImmune, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MedImmune, LLC Mergers and Acqu …
  • Organon BioSciences N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Organon BioSciences N.V. Merger …
  • Clean Energy Fuels Corp. (CLNE):企業の財務及び戦略的SWOT分析
    Summary Clean Energy Fuels Corp. (Clean Energy) is a natural gas fuel provider that offers natural gas fuel for transportation in North America. The company offers products, which include compressors, dispensers, storage systems and CNG parts. It offers services such as engineering and construction, …
  • Dehaier Medical Systems Limited (formerly De-Haier Medical Systems Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dehaier Medical Systems Limited …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆